Thank you for your inquiry about CMS117v14 (2026 Performance Period). We do not provide prescriptive mapping guidance on the value sets. Clinically equivalent services may be mapped to the codes used in CMS117v14 to satisfy the numerator requirements. If the vaccine includes multiple antigens, it can be mapped to multiple value sets. For example, you may map a code for each of the individual antigens included in the vaxelis vaccine (e.g. one code for DTaP, IPV, HiB, and Hep B). If mapping is done, you should maintain documentation in case of a CMS audit. If you have questions about reading the measure specification or understanding data requirements, you may refer to the "Guide for Reading eCQMs" for additional guidance. If you have questions regarding implementing the measure, you may refer to the "Implementation Checklist for eCQM Annual Update" for additional guidance. These resources can be found in the eCQI Resource Center: https://ecqi.healthit.gov/ep-ec?qt-tabs_ep=ecqm-resources&global_measure_group=eCQMs . If you have questions regarding CMS quality program reporting requirements, please review the QPP website or contact the QPP Helpdesk at QPP@cms.hhs.gov .

Can you please provide guidance on proper mapping of the Dtap-Ipv-Hib-Hepb vaccine for Vaxelis specifically? We see this maps to CVX 146 but that requires a 4-dose scheduled, but on the manufacturer website they specify that this is a 3-dose vaccine. This is causing our physicians/APP to fail the measure because they are administering 3-doses for Vaxelis.